HEXCEED Trademark

Trademark Overview


On Tuesday, May 14, 2019, a trademark application was filed for HEXCEED with the United States Patent and Trademark Office. The USPTO has given the HEXCEED trademark a serial number of 79265244. The federal status of this trademark filing is REGISTERED as of Tuesday, May 19, 2020. This trademark is owned by Genmab B.V.. The HEXCEED trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, Personal, and Legal & Social Services categories with the following description:

Pharmaceutical and veterinary preparations, namely, pharmaceutical preparations based on antibodies, and bi- and multispecific antibodies as well as antibody fragments, including monovalent antibodies, derivatives or conjugates of any of these for use with regard to the treatment of cancer, infectious, immune, autoimmune, inflammatory, neurodegenerative and cardiovascular diseases

Legal services in the field of patent exploitation; licensing of intellectual property in the field of medicine

Chemical, biochemical, biological, and biotechnological, preparations, namely, antibodies, bi- and multispecific antibodies as well as antibody fragments, monovalent antibodies, and derivatives of conjugates of any of these for in vitro and in vivo scientific and industrial research and development with regard to diseases; active chemical ingredients for use in the manufacture of pharmaceuticals

Medical scientific and biological research, namely research into antibodies and bi- and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these and development of pharmaceutical products based on antibodies and bi- and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these; chemical analysis; computer programming, namely programming of computers for the collection and processing of medical data in medical scientific research, development and therapy, including scientific research, development and therapy with antibodies and bi- and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these
hexceed

General Information


Serial Number79265244
Word MarkHEXCEED
Filing DateTuesday, May 14, 2019
Status700 - REGISTERED
Status DateTuesday, May 19, 2020
Registration Number6055660
Registration DateTuesday, May 19, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 3, 2020

Trademark Statements


Goods and ServicesPharmaceutical and veterinary preparations, namely, pharmaceutical preparations based on antibodies, and bi- and multispecific antibodies as well as antibody fragments, including monovalent antibodies, derivatives or conjugates of any of these for use with regard to the treatment of cancer, infectious, immune, autoimmune, inflammatory, neurodegenerative and cardiovascular diseases
Goods and ServicesLegal services in the field of patent exploitation; licensing of intellectual property in the field of medicine
Goods and ServicesChemical, biochemical, biological, and biotechnological, preparations, namely, antibodies, bi- and multispecific antibodies as well as antibody fragments, monovalent antibodies, and derivatives of conjugates of any of these for in vitro and in vivo scientific and industrial research and development with regard to diseases; active chemical ingredients for use in the manufacture of pharmaceuticals
Goods and ServicesMedical scientific and biological research, namely research into antibodies and bi- and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these and development of pharmaceutical products based on antibodies and bi- and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these; chemical analysis; computer programming, namely programming of computers for the collection and processing of medical data in medical scientific research, development and therapy, including scientific research, development and therapy with antibodies and bi- and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, August 27, 2019
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 27, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, August 27, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, August 27, 2019
Primary Code045
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGenmab B.V.
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressNL

Party NameGenmab B.V.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNL

Party NameGenmab B.V.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNL

Trademark Events


Event DateEvent Description
Saturday, August 31, 2019APPLICATION FILING RECEIPT MAILED
Thursday, August 15, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, August 27, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 27, 2019ASSIGNED TO EXAMINER
Tuesday, September 3, 2019NON-FINAL ACTION WRITTEN
Wednesday, September 4, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, September 18, 2019NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Thursday, September 19, 2019NON-FINAL ACTION WRITTEN
Friday, September 20, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, October 10, 2019REFUSAL PROCESSED BY MPU
Friday, October 11, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, November 2, 2019REFUSAL PROCESSED BY IB
Thursday, January 9, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 9, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 9, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 30, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 12, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 12, 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 12, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, March 3, 2020PUBLISHED FOR OPPOSITION
Tuesday, March 3, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 19, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, August 19, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, September 19, 2020FINAL DISPOSITION PROCESSED
Saturday, September 19, 2020FINAL DISPOSITION NOTICE SENT TO IB
Sunday, October 11, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, February 28, 2020NOTIFICATION PROCESSED BY IB
Wednesday, June 5, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 5, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 5, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, June 5, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, June 5, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, June 5, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, May 19, 2025COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, April 24, 2025NEW REPRESENTATIVE AT IB RECEIVED